Patent · US Active

Indoline anti-cancer agents

US7989482B2 · kind B2 · utility

1Cited by
7References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 29, 2009
Grant dateAug 2, 2011
Priority date
Expiry dateFeb 5, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D498/22
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Indoline compounds having anti-mitotic activity, useful for the treatment of cancer and other proliferative disorders are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.